J. Young

发表

Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.

M. Pfeffer, S. Yusuf, J. McMurray, 2000, American heart journal.

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group.

K. Dickstein, J. Cleland, James B. Young, 1995, Circulation.

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

Janzen, A. M. Møller, D. Debanne, 1996, The Canadian journal of cardiology.

Double‐blind controlled trials of Cronassial in chronic neuromuscular diseases and ataxia

G. Badger, W. Bradley, R. Tandan, 1988, Neurology.

High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients.

E. Tuzcu, P. McCarthy, M. Goormastic, 1998, Transplantation.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Stephanie D. Wilson, S. Ellias, J. Nutt, 2014, JAMA neurology.

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

S. Yusuf, R. McKelvie, J. Pogue, 1999, Circulation.

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

S. Yusuf, B. Hoogwerf, B. Zinman, 2001, JAMA.

Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial.

M. Bergeron, K. Riding, J. Richard, 1987, The Pediatric infectious disease journal.

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.

C B Granger, M. Pfeffer, R. Califf, 1999, European heart journal.

Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators.

S. Yusuf, J. Pogue, B. Hoogwerf, 2000, Diabetes care.